Ivermectin Beats Out 9 Other Meds for Treating Omicron, Study Confirms • Children’s Health Defense

Researchers used computational analyses to evaluate the performance of 10 medications against the Omicron variant, finding that ivermectin outperformed all of them, including nirmatrelvir (Paxlovid) a new drug from Pfizer that has cost taxpayers $5.29 billion and costs $529 per course of treatment.

Ivermectin lowers the viral load by inhibiting replication, reduces infection by 86% when used preventively, speeds recovery, protects against organ damage, lowers the risk of hospitalization and death and costs between $48 and $95 for a course of treatment depending on your location.

Early treatment lowers your risk of long COVID, which includes physical and mental health conditions. According to cardiologist Dr. Peter McCullough, 50% of those sick enough to be hospitalized have symptoms of long COVID.

Emergency use authorizations for drugs that have not proven to be effective in trials, public mask mandates for which there is no scientific evidence and the suppression and censorship of health information has boosted public fear over a viral illness with a survival rate of over 99%.

Ivermectin Beats Out 9 Other Meds for Treating Omicron, Study Confirms • Children’s Health Defense